• ქართული
  • English
  • Gilead Sciences snares Roche veteran O'Day as CEO

    Drugmaker Gilead Sciences Inc on Monday named Roche Holding AG’s Daniel O’Day as its new chief executive, tapping an industry veteran to fill a management vacuum.

    Market Quotes by TradingView